Brief electric shocks may help the body better respond to certain kinds of experimental AIDS vaccines, U.S. researchers said Oct. 22.
Brief electric shocks may help the body better respond to certain kinds of experimental AIDS vaccines, U.S. researchers said Oct. 22.
ARUSHA, Tanzania — The Bill & Melinda Gates Foundation announced 76 grants of $100,000 each to pursue bold ideas for transforming health in developing countries.
CHICAGO — There is nothing unique or scary about the new H1N1 flu vaccine that should keep people from getting it, said Dr. Francis Collins, director of the U.S. National Institutes of Health.
The first clinical trials to test whether the 2009 H1N1 influenza vaccine can safely elicit a protective immune response in HIV-infect
With all the attention on H1N1 and the seasonal flu, it might be easy to forget about other infectious diseases.
The Oxford-Emergent Tuberculosis Consortium Ltd. has signed an agreement with Vivalis to evaluate large-scale commercial production capabilities for MVA85A, the consortium’s new TB vaccine candidate.
ROCKVILLE, Md. — Novavax has received a grant to support preclinical research of a vaccine for the most commonly identified cause of lower respiratory illnesses in infants and young children.
When promising results from a large clinical trial of an AIDS vaccine regimen were announced recently, it was good news to the inventor of one of the vaccines used in the trial.
BLACKSBURG, Va. — Virginia Tech will use $27 million to support infectious disease research around the world.
A cholera vaccine has proved to be safe and effective in young children in a part of India where the disease is endemic, a new study in The Lancet says.